{{Rsnum
|rsid=2052550
|Gene=ARSB
|Chromosome=5
|position=78977119
|Orientation=minus
|GMAF=0.4885
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ARSB
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 9.2 | 27.7 | 63.1
| HCB | 31.8 | 52.3 | 15.9
| JPT | 28.4 | 56.0 | 15.6
| YRI | 56.6 | 35.2 | 8.3
| ASW | 38.2 | 54.5 | 7.3
| CHB | 31.8 | 52.3 | 15.9
| CHD | 26.7 | 53.3 | 20.0
| GIH | 23.5 | 52.0 | 24.5
| LWK | 62.4 | 35.8 | 1.8
| MEX | 28.1 | 47.4 | 24.6
| MKK | 38.7 | 45.2 | 16.1
| TSI | 6.1 | 40.4 | 53.5
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19084217
|Trait=Serum markers of iron status
|Title=Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels
|RiskAllele=
|Pval=0.000008
|OR=NR
|ORtxt=NR
|OA=1
}}

{{PharmGKB
|RSID=rs2052550
|Name_s=
|Gene_s=ARSB
|Feature=
|Evidence=PubMed ID:19084217; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels. (Initial Sample Size: 459 twin pairs; Replication Sample Size: NR); (Region: 5q14.1; Reported Gene(s): ARSB; Risk Allele: rs2052550-?); (p-value= 0.000008).This variant is associated with Serum markers of iron status.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740115
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2052550
|overall_frequency_n=62
|overall_frequency_d=128
|overall_frequency=0.484375
|n_genomes=34
|n_genomes_annotated=0
|n_haplomes=51
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}